Study to evaluate efficacy and safety of inclisiran in adolescents with homozygous familial hypercholesterolemia Study to evaluate efficacy and safety of inclisiran in adolescents with homozygous familial hypercho ...
Two part (double-blind) inclisiran versus placebo [Year 1] followed by open-label inclisiran [Year 2] randomized multicentre study to evaluate safety, tolerability, and efficacy of inclisiran in adolescents (12 to less than 18 years) with homozygous familial hypercholesterolemia and elevated LDL-cholesterol (ORION-13) Two part (double-blind) inclisiran versus placebo [Year 1] followed by open-label inclisiran [Year 2 ...